Drug intelligence / Profile preview

rizolipase

Development stage
Unknown
Lead developer
Repha
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Rizolipase is a fungal-derived lipase obtained from the mold *Rhizopus oryzae*, used as a pancreatic enzyme replacement therapy (PERT) for exocrine pancreatic insufficiency (EPI). It is particularly indicated for malabsorption associated with post-gastrectomy syndrome and chronic pancreatitis. Developed in collaboration with researchers at the University of Leipzig, rizolipase is distinguished from porcine-derived pancreatin by its inherent acid stability, remaining active across a broad pH range (3.0 to 9.0). This stability allows the enzyme to function effectively in the stomach and proximal small intestine without the requirement for enteric coating, making it highly suitable for patients with altered gastric anatomy or rapid gastric emptying where traditional enteric-coated microspheres may fail to synchronize with the chyme. Rizolipase catalyzes the hydrolysis of dietary triglycerides into absorbable fatty acids and monoglycerides, thereby improving fat digestion and nutritional status.

Brand names
Nortase
Other names
fungal lipaseRhizopus oryzae lipase

Beyond the preview

Go deeper on rizolipase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rizolipase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call